AnaptysBio, Inc. (ANAB)
54.19
-1.27
(-2.29%)
USD |
NASDAQ |
Feb 20, 16:00
54.25
+0.06
(+0.11%)
After-Hours: 20:00
AnaptysBio SG&A Expense (Quarterly) : 10.21M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 62.98M |
| Nektar Therapeutics | 16.07M |
| Rigel Pharmaceuticals, Inc. | 28.94M |
| CorMedix, Inc. | 36.64M |
| Verastem, Inc. | 21.01M |